RTC
ATRS

Riverview Trust Company’s Antares Pharma, Inc. ATRS Stock Holding History

Riverview Trust Company’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,192
Closed -$17K – 899
2022
Q1 		$17K Buy
+4,192
New +$15.2K 0.01% 576

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Riverview Trust Company's ATRS Position: Q2 2022 in Review

Riverview Trust Company sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 4,192 shares — an estimated $17K sold.

Riverview Trust Company first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $17K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Riverview Trust Company reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Riverview Trust Company sold 4,192 Antares Pharma, Inc. shares in Q2 2022, an estimated $17K.
  • Riverview Trust Company first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Riverview Trust Company's Antares Pharma, Inc. position peaked at $17K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Riverview Trust Company's 13F filing for Q2 2022, filed 27 Jul 2022.